Health-Economic Analyses of subcutaneous Specific Immunotherapy for grass pollen and mite allergy

1999

Bousquet, 2001, Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, 108

van, 2000, Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology, Allergy, 55, 116, 10.1034/j.1398-9995.2000.00526.x

Malling, 2004, Immunotherapy for allergic rhinoconjunctivitis, Clin Allergy Immunol, 18, 495

Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, N Engl J Med, 341, 468, 10.1056/NEJM199908123410702

Pajno, 2001, Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study, Clin Exp Allergy, 31, 1392, 10.1046/j.1365-2222.2001.01161.x

Purello-D’Ambrosio, 2001, Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study, Clin Exp Allergy, 31, 1295, 10.1046/j.1365-2222.2001.01027.x

Abramson, 2000, Allergen immunotherapy for asthma, Cochrane Database Syst Rev

Walker, 2001, Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial, J Allergy Clin Immunol, 107, 87, 10.1067/mai.2001.112027

Mungan, 1999, Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study, Ann Allergy Asthma Immunol, 82, 485, 10.1016/S1081-1206(10)62726-3

Winther, 2000, Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects, Allergy, 55, 827, 10.1034/j.1398-9995.2000.00368.x

Kozma, 1996, Economic outcomes for the treatment of allergic rhinitis, Pharmacoeconomics, 10, 4, 10.2165/00019053-199610010-00002

Jarolim, 1990, A long-term follow-up study of hyposensitization with immunoblotting, J Allergy Clin Immunol, 85, 996, 10.1016/0091-6749(90)90043-4

Le, 1995, Health and Number: Basic Biostatistical Methods, Wiley-Liss

Malling, 2003, Immunotherapy for rhinitis, Curr Allergy Asthma Rep, 3, 204, 10.1007/s11882-003-0040-7

Mosbech, 1988, Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis, Allergy, 43, 523, 10.1111/j.1398-9995.1988.tb01631.x

Pichler, 2001, Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity, Allergy, 56, 301, 10.1034/j.1398-9995.2001.00834.x

Schadlich, 2000, Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany, Pharmacoeconomics, 17, 37, 10.2165/00019053-200017010-00003

Walker, 1995, Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study, Allergy, 50, 405, 10.1111/j.1398-9995.1995.tb01170.x

Zenner, 1997, Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis, J Allergy Clin Immunol, 100, 23, 10.1016/S0091-6749(97)70190-8

Yawn, 1999, Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges, J Allergy Clin Immunol, 103, 54, 10.1016/S0091-6749(99)70525-7